Sakar Healthcare Limited (SAKAR) — Financial Results Announcement
📢 Key Event
Board meeting scheduled for audited FY2025-26 financial results approval
💡 Investor Takeaway
The board will review and approve audited financial results for the full fiscal year ending March 31, 2026.
Sakar Healthcare Limited announced a board meeting on May 12, 2026 to approve audited standalone and consolidated financial results for FY2025-26 ending March 31, 2026, following prior notice dated March 24, 2026.
📄 View Original Announcement (PDF)
About Sakar Healthcare Limited (SAKAR)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹1,550.15 Cr
P/E: 102.3
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.